Steripet 250 MBq/ml Oplossing voor injectie

DRUG2 trials

Sponsors

University Hospital Maastricht, Academisch Ziekenhuis Maastricht

Conditions

Hormone-positive breast cancerNon-small cell lung cancer

Phase 2

18F-FDG versus 68Ga-FAPI-46 as PET tracer in ER-positive breast cancer - a pilot study

Not yet recruitingCTIS2023-508066-15-01

University Hospital MaastrichtHormone-positive breast cancer

Target: 20Updated: 2025-06-23

Improved baseline staging with 68Ga-FAPI-46 PET in non-small cell lung cancer – a pilot study

Not yet recruitingCTIS2025-523032-39-00

Academisch Ziekenhuis MaastrichtNon-small cell lung cancer

Target: 10Updated: 2026-02-03